Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cavitation Technologies (CVAT) Shares Outstanding (2016 - 2025)

Cavitation Technologies' Shares Outstanding history spans 15 years, with the latest figure at $309.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 8.95% year-over-year to $309.7 million; the TTM value through Dec 2025 reached $309.7 million, up 8.95%, while the annual FY2025 figure was $289.2 million, 1.71% up from the prior year.
  • Shares Outstanding for Q4 2025 was $309.7 million at Cavitation Technologies, up from $289.2 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $309.7 million in Q4 2025 and bottomed at $197.0 million in Q1 2021.
  • The 5-year median for Shares Outstanding is $284.3 million (2023), against an average of $271.2 million.
  • The largest annual shift saw Shares Outstanding changed 0.0% in 2021 before it soared 38.43% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $254.7 million in 2021, then grew by 8.64% to $276.7 million in 2022, then grew by 2.74% to $284.3 million in 2023, then changed by 0.0% to $284.3 million in 2024, then increased by 8.95% to $309.7 million in 2025.
  • Per Business Quant, the three most recent readings for CVAT's Shares Outstanding are $309.7 million (Q4 2025), $289.2 million (Q3 2025), and $289.2 million (Q2 2025).